WHO classification 2010 for the lower gastrointestinal tract: what is new? (Q34019220)

30 July 2017

title

WHO classification 2010 for the lower gastrointestinal tract: what is new? (English)

1 reference

World Health Organization

30 July 2017

main subject

0 references

author name string

D E Aust

series ordinal

1

1 reference

30 July 2017

language of work or name

German

0 references

publication date

1 November 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

32 Suppl 2

1 reference

30 July 2017

page(s)

326-331

1 reference

Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Cancer surveillance in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Molecular profiling of ulcerative colitis-associated neoplastic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Diagnostic standards in the pathology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Thymidylate synthase gene variations: predictive and prognostic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Colorectal serrated adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Significance of signet-ring cells in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Cancer surveillance in inflammatory bowel disease: new molecular approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Primary invasive micropapillary carcinoma of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Endoscopic and pathological aspects of colitis-associated dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00292-011-1505-4

Loss of heterozygosity and microsatellite instability in non-neoplastic mucosa from patients with chronic ulcerative colitis

21 January 2018

1 reference

12 December 2020

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab

1 reference

12 December 2020

[Development of molecular-pathologic entities of colorectal cancer]

1 reference

12 December 2020

Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?

1 reference

12 December 2020

Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis

1 reference

12 December 2020

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

12 December 2020

Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation

1 reference

12 December 2020

Colorectal adenomas in patients presenting with inflammatory bowel disease

1 reference

12 December 2020

Venous invasion detection in colorectal cancer: which approach, which technique?

1 reference

12 December 2020

Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdomino

1 reference

12 December 2020

Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status: relation with their sensitivity to CTP-11.

1 reference

12 December 2020

Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum

1 reference

12 December 2020

10.1007/S00292-011-1505-4

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1048332922

0 references

1 reference